MED MEDIFAST INC Common Stock

NYSE · Consumer products · Auf SEC EDGAR ansehen ↗
$11,31
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 3, 2026

Über MEDIFAST INC Common Stock Unternehmensübersicht von Wikipedia

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Mehr lesen

Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Subsidiaries

The company owns five subsidiaries:

Jason Pharmaceuticals, Inc.

Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)

Jason Enterprises, Inc.

Jason Properties, LLC

Seven Crondall, LLC

History

William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.

The company is publicly traded on the New York Stock Exchange (symbol: MED).

On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.

In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”

In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.

Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.

In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.

In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.

In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.

False advertising settlement

In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

MED Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$11.31
Marktkapitalisierung
$124M
P/E (TTM)
-6.7
EPS (TTM)
$-1.70
Umsatz (TTM)
$386M
Dividendenrendite
0.16%
ROE
-9.0%
Verschuldungsgrad
52W-Spanne
$9 – $15

MED Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $386M
10-point trend, +40.5%
2016-12-31 2025-12-31
EPS $-1.70
10-point trend, -214.1%
2016-12-31 2025-12-31
Freier Cashflow $1M
10-point trend, -94.4%
2016-12-31 2025-12-31
Margen -4.8%
10-point trend, -4.8%
2016-12-31 2025-12-31

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
MED
Peer-Median
P/E (TTM)
5-point trend, -141.7%
-6.7
14.8
P/S (TTM) (K/V (TTM))
5-point trend, -80.9%
0.3
0.7
P/B (K/B)
5-point trend, -95.1%
0.6
2.9
Price / FCF (Kurs / FCF)
5-point trend, +133.6%
99.5

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
MED
Peer-Median
Gross Margin (Bruttogewinnmarge)
5-point trend, -3.5%
71.3%
69.3%
Operating Margin (Betriebsgewinnmarge)
5-point trend, -126.0%
-3.7%
Net Profit Margin (Nettogewinnmarge)
5-point trend, -145.0%
-4.8%
4.4%
ROA
5-point trend, -114.4%
-7.0%
6.3%
ROE
5-point trend, -110.9%
-9.0%
14.0%
ROIC
5-point trend, -129.2%
-23.7%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
MED
Peer-Median
Current Ratio (Liquiditätsgrad)
5-point trend, +159.8%
4.7
2.4
Quick Ratio
5-point trend, +503.6%
3.9

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
MED
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, -74.7%
-36.0%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, -74.7%
-37.7%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, -74.7%
-16.2%
EPS YoY (EPS VjV)
5-point trend, -112.2%
-97.9%
Net Income YoY (Nettogewinn YoY)
5-point trend, -111.4%
-97.9%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
MED
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, -112.2%
$-1.70

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
MED
Peer-Median
Payout Ratio (Ausschüttungsquote)
5-point trend, -102.7%
-1.0%

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

Dividendenrendite
0.16%
Ausschüttungsquote
-1.0%
5J Div CAGR
Ex-DatumBetrag
18. September 2023$1,6500
26. Juni 2023$1,6500
27. März 2023$1,6500
19. Dezember 2022$1,6400
19. September 2022$1,6400
27. Juni 2022$1,6400
28. März 2022$1,6400
20. Dezember 2021$1,4200
20. September 2021$1,4200
21. Juni 2021$1,4200
29. März 2021$1,4200
21. Dezember 2020$1,1300
21. September 2020$1,1300
29. Juni 2020$1,1300
30. März 2020$1,1300
26. Dezember 2019$1,1300
26. September 2019$0,7500
27. Juni 2019$0,7500
28. März 2019$0,7500
20. Dezember 2018$0,7500

MED Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

VERKAUF 9 Analysten
  • Starker Kauf 0 0,0%
  • Kauf 0 0,0%
  • Halten 4 44,4%
  • Verkauf 4 44,4%
  • Starker Verkauf 1 11,1%

12-Monats-Kursziel

1 Analysten · 2026-08-16
Median-Ziel $12.00 +6,1%
Mittelwert-Ziel $12.00 +6,1%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.11%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $-0.28 $-0.66 0.38%
31. März 2026 $-0.19 $-0.53 0.34%
31. Dezember 2025 $-1.65 $-0.83 -0.82%
30. September 2025 $-0.21 $-0.39 0.18%
30. Juni 2025 $0.22 $-0.22 0.44%
31. März 2025 $-0.11 $-0.27 0.16%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NUS 3.0 -14.3% 10.8% 22.0% 69.5%
FTLF 25.8 26.4%
SKIN $177M -8.7 -10.0% -3.2% -14.1% 65.3%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 15
Jährliche Gewinn- und Verlustrechnung-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +35.2% $386M $602M $1.07B $1.60B $1.53B $935M $714M $501M $302M $275M $273M $285M
Cost of Revenue 12-point trend, +45.4% $111M $158M $296M $458M $398M $237M $177M $121M $74M $69M $71M $76M
Gross Profit 12-point trend, +31.5% $275M $445M $776M $1.14B $1.13B $698M $537M $380M $228M $206M $201M $209M
R&D Expense 12-point trend, +230.8% $4M $5M $5M $4M $4M $3M $3M $2M $2M $2M $2M $1M
SG&A Expense 12-point trend, +61.7% $289M $442M $649M $956M $911M $564M $446M $311M $188M $179M $173M $179M
Operating Income 12-point trend, -147.0% $-14M $3M $126M $185M $216M $134M $91M $69M $40M $27M $29M $30M
Other Non-op 12-point trend, +318.3% $3M $-4M $-95.0K $-747.0K $119.0K $-140.0K $29.0K $179.0K $136.0K $-20.0K $326.0K $731.0K
Pretax Income 12-point trend, -117.8% $-6M $4M $129M $184M $216M $134M $92M $71M $40M $27M $30M $32M
Income Tax 12-point trend, +22.2% $13M $2M $29M $40M $52M $31M $14M $15M $13M $9M $10M $11M
Net Income 12-point trend, -241.7% $-19M $2M $99M $144M $164M $103M $78M $56M $28M $18M $20M $13M
EPS (Basic) 12-point trend, -263.5% $-1.70 $0.19 $9.13 $12.82 $14.01 $8.74 $6.62 $4.67 $2.32 $1.51 $1.68 $1.04
EPS (Diluted) 12-point trend, -265.0% $-1.70 $0.19 $9.10 $12.73 $13.89 $8.68 $6.43 $4.62 $2.29 $1.49 $1.66 $1.03
Shares (Basic) 12-point trend, -13.3% 10,981,000 10,930,000 10,884,000 11,195,000 11,705,000 11,771,000 11,771,000 11,947,000 11,924,000 11,842,000 11,959,000 12,670,000
Shares (Diluted) 12-point trend, -14.1% 10,981,000 10,963,000 10,921,000 11,276,000 11,813,000 11,850,000 12,117,000 12,079,000 12,088,000 11,947,000 12,071,000 12,778,000
EBITDA 11-point trend, -99.9% $29.0K $16M $140M $196M $223M $141M $96M $73M $44M $32M $36M ·
Bilanz 24
Jährliche Bilanz-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +265.1% $89M $91M $94M $88M $104M $164M $77M $81M $75M $52M $42M $24M
Short-term Investments 12-point trend, +176.6% $78M $71M $56M $0 $5M $11M $16M $20M $24M $24M $25M $28M
Receivables 7-point trend, -64.6% · · · · · $584.0K $1M $1M $576.0K $1M $2M $2M
Inventory 12-point trend, +28.6% $20M $42M $55M $119M $180M $53M $49M $39M $19M $18M $13M $16M
Prepaid Expense 12-point trend, +215.3% $9M $10M $11M $16M $16M $6M $6M $5M $4M $4M $3M $3M
Current Assets 12-point trend, +146.2% $202M $214M $224M $223M $307M $234M $154M $146M $125M $101M $87M $82M
PP&E (Net) 12-point trend, -6.7% $31M $38M $51M $57M $56M $28M $26M $20M $19M $20M $29M $33M
PP&E (Gross) 12-point trend, +35.0% $99M $96M $99M $97M $89M $55M $49M $54M $52M $56M $75M $74M
Accum. Depreciation 12-point trend, +69.8% $68M $58M $47M $40M $33M $27M $23M $35M $33M $36M $46M $40M
Other Non-current Assets 12-point trend, +1475.1% $8M $10M $15M $12M $6M $3M $353.0K $1M $2M $162.0K $205.0K $497.0K
Total Assets 12-point trend, +113.9% $248M $284M $310M $316M $398M $276M $195M $169M $146M $121M $116M $116M
Accounts Payable 12-point trend, +75.5% $38M $56M $86M $135M $163M $108M $76M $60M $37M $24M $23M $22M
Current Liabilities 12-point trend, +59.4% $43M $64M $92M $141M $170M $111M $79M $60M $37M $24M $24M $27M
Capital Leases 9-point trend, +2416.9% $6M $10M $16M $20M $26M $7M $10M · · · $0 $242.0K
Deferred Tax 4-point trend, -96.2% · · · · · · · · $208.0K $779.0K $4M $5M
Total Liabilities 12-point trend, +38.4% $49M $74M $108M $161M $196M $119M $90M $60M $37M $25M $28M $35M
Common Stock 12-point trend, -8.3% $11.0K $11.0K $11.0K $11.0K $12.0K $12.0K $12.0K $12.0K $12.0K $12.0K $12.0K $12.0K
Paid-in Capital 11-point trend, +3469.4% $40M $33M $27M $22M $12M $8M · $9M $5M $3M $0 $1M
Retained Earnings 12-point trend, +100.6% $158M $177M $175M $140M $190M $154M $169M $131M $104M $93M $89M $79M
Treasury Stock 7-point trend, +0.00 · · $0 $6M $0 $5M $64M $31M · · · $0
AOCI 12-point trend, -46.2% $234.0K $180.0K $248.0K $24.0K $111.0K $41.0K $25.0K $-173.0K $-160.0K $-165.0K $-62.0K $435.0K
Stockholders' Equity 12-point trend, +147.2% $199M $210M $201M $155M $202M $157M $105M $109M $107M $96M $89M $80M
Liabilities + Equity 12-point trend, +113.9% $248M $284M $310M $316M $398M $276M $195M $169M $146M $121M $116M $116M
Shares Outstanding 12-point trend, -9.0% 10,991,000 10,938,000 10,896,000 10,873,000 11,593,000 11,772,000 11,764,000 11,868,000 11,971,000 11,871,000 11,797,000 12,075,764
Cashflow 16
Jährliche Cashflow-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +76.9% $14M $13M $13M $11M $7M $4M $5M $4M $4M $5M $7M $8M
Stock-based Comp 12-point trend, +95.0% $8M $7M $8M $11M $10M $7M $5M $3M $4M $3M $3M $4M
Deferred Tax 12-point trend, +3907.0% $11M $-7M $1M $-924.0K $-4M $601.0K $2M $-3M $-623.0K $-3M $-106.0K $286.0K
Restructuring · · · · · · · · · $1M · ·
Other Non-cash 11-point trend, -959.2% $-8M $10M $26M $30M $-82M $28M $-4M $155.0K $8M $2M $-737.0K ·
Operating Cash Flow 12-point trend, -73.1% $7M $24M $148M $195M $95M $145M $84M $61M $43M $25M $29M $26M
CapEx 12-point trend, -20.1% $6M $7M $6M $17M $34M $6M $10M $5M $3M $3M $3M $7M
Investing Cash Flow 12-point trend, -214.9% $-8M $-27M $-61M $-11M $-29M $-1M $-6M $-1M $-3M $-2M $-189.0K $-3M
Net Debt Issued 2-point trend, +14.1% · · · · · · · · · $-219.0K $-255.0K ·
Stock Repurchased 10-point trend, -100.0% $0 $0 $4M $126M $56M $5M $33M $30M · · $11M $34M
Net Stock Activity 9-point trend, +100.0% $0 $0 $-4M $-126M $-56M $-5M $-33M $-30M · · $-11M ·
Dividends Paid 10-point trend, -98.4% $195.0K $715.0K $73M $72M $64M $53M $35M $23M $15M $12M · ·
Financing Cash Flow 12-point trend, +98.4% $-564.0K $-2M $-80M $-200M $-125M $-57M $-82M $-53M $-17M $-13M $-12M $-35M
Net Change in Cash 12-point trend, +86.4% $-2M $-4M $7M $-16M $-60M $87M $-4M $6M $23M $10M $18M $-12M
Taxes Paid 4-point trend, -71.9% $10M $-2M $34M $37M · · · · · · · ·
Free Cash Flow 11-point trend, -95.3% $1M $17M $141M $178M $60M $139M $74M $56M $40M $22M $27M ·
Rentabilität 8
Jährliche Rentabilität-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Gross Margin 11-point trend, -3.3% 71.3% 73.8% 72.4% 71.3% 73.9% 74.7% 75.2% 75.8% 75.5% 74.9% 73.8% ·
Operating Margin 11-point trend, -135.0% -3.7% 0.48% 11.8% 11.6% 14.2% 14.3% 12.8% 13.8% 13.1% 9.8% 10.5% ·
Net Margin 11-point trend, -165.9% -4.8% 0.35% 9.3% 9.0% 10.8% 11.0% 10.9% 11.1% 9.2% 6.5% 7.3% ·
Pretax Margin 11-point trend, -113.4% -1.5% 0.63% 12.0% 11.5% 14.2% 14.4% 12.9% 14.1% 13.4% 9.9% 10.9% ·
EBITDA Margin 11-point trend, -99.9% 0.01% 2.6% 13.0% 12.2% 14.6% 15.1% 13.4% 14.7% 14.5% 11.8% 13.1% ·
ROA 11-point trend, -140.8% -7.0% 0.70% 31.8% 40.2% 48.6% 43.7% 42.8% 35.4% 20.8% 15.0% 17.2% ·
ROE 11-point trend, -137.9% -9.0% 1.0% 50.4% 94.0% 82.3% 69.2% 72.1% 50.5% 27.1% 19.3% 23.7% ·
ROIC 11-point trend, -210.8% -23.7% 0.76% 48.4% 93.0% 81.1% 65.4% 73.3% 50.1% 25.1% 18.4% 21.3% ·
Liquidität & Solvenz 2
Jährliche Liquidität & Solvenz-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, +25.6% 4.7 3.3 2.4 1.6 1.8 2.1 1.9 2.4 3.4 4.1 3.7 ·
Quick Ratio 11-point trend, +33.5% 3.9 2.5 1.0 0.6 0.6 1.6 1.2 1.7 2.7 3.2 2.9 ·
Effizienz 3
Jährliche Effizienz-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -38.0% 1.4 2.0 3.4 4.5 4.5 4.0 3.9 3.2 2.3 2.3 2.3 ·
Inventory Turnover 11-point trend, -28.2% 3.5 3.3 3.4 3.1 3.4 4.6 4.0 4.1 3.9 4.4 4.9 ·
Receivables Turnover 6-point trend, +456.7% · · · · · 925.1 583.1 467.4 307.2 181.8 166.2 ·
Pro Aktie 6
Jährliche Pro Aktie-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share 11-point trend, +141.0% $18.10 $19.21 $18.49 $14.26 $17.47 $13.36 $8.91 $9.19 $9.07 $8.09 $7.51 ·
Revenue / Share 11-point trend, +55.5% $35.13 $54.95 $98.16 $141.77 $129.19 $78.89 $58.90 $41.48 $24.95 $22.98 $22.60 ·
Cash Flow / Share 11-point trend, -74.3% $0.62 $2.23 $13.52 $17.26 $8.00 $12.25 $6.95 $5.03 $3.58 $2.12 $2.44 ·
Cash / Share 11-point trend, +128.0% $8.13 $8.31 $8.67 $8.06 $8.99 $13.91 $6.54 $6.86 $6.27 $4.42 $3.56 ·
Dividend / Share 12-point trend, +0.00 $0 $0 $5 $7 $6 $5 $3 $2 $1 $1 $0 $0
EPS (TTM) 12-point trend, -265.0% $-1.70 $0.19 $9.10 $12.73 $13.89 $8.68 $6.43 $4.62 $2.29 $1.49 $1.66 $1.03
Wachstumsraten 8
Jährliche Wachstumsraten-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -156.9% -36.0% -43.8% -32.9% 4.8% 63.2% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -908.1% -37.7% -26.6% 4.7% · · · · · · · · ·
Revenue CAGR 5Y -16.2% · · · · · · · · · · ·
EPS YoY 4-point trend, -263.1% · -97.9% -28.5% -8.3% 60.0% · · · · · · ·
EPS CAGR 3Y 2-point trend, -4884.9% · -76.1% 1.6% · · · · · · · · ·
Net Income YoY 4-point trend, -264.6% · -97.9% -30.8% -12.5% 59.5% · · · · · · ·
Net Income CAGR 3Y 2-point trend, -6682.3% · -76.6% -1.1% · · · · · · · · ·
Dividend CAGR 5Y -67.4% · · · · · · · · · · ·
Bewertung (TTM) 13
Jährliche Bewertung (TTM)-Daten für MED
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +35.2% $386M $602M $1.07B $1.60B $1.53B $935M $714M $501M $302M $275M $273M $285M
Net Income TTM 12-point trend, -241.7% $-19M $2M $99M $144M $164M $103M $78M $56M $28M $18M $20M $13M
Market Cap 11-point trend, -67.2% $117M $193M $732M $1.25B $2.43B $2.31B $1.29B $1.48B $836M $494M $358M ·
P/E 12-point trend, -119.3% -6.3 92.7 7.4 9.1 15.1 22.6 17.0 27.1 30.5 27.9 18.3 32.6
P/S 11-point trend, -76.8% 0.3 0.3 0.7 0.8 1.6 2.5 1.8 3.0 2.8 1.8 1.3 ·
P/B 11-point trend, -85.4% 0.6 0.9 3.6 8.1 12.0 14.7 12.3 13.6 7.7 5.1 4.0 ·
P / Tangible Book 6-point trend, -96.0% 0.6 0.9 3.6 8.1 12.0 14.7 · · · · · ·
P / Cash Flow 11-point trend, +40.4% 17.1 7.9 5.0 6.4 25.7 15.9 15.3 24.4 19.3 19.5 12.2 ·
P / FCF 11-point trend, +597.3% 94.0 11.3 5.2 7.1 40.2 16.6 17.4 26.6 20.9 22.0 13.5 ·
Dividend Yield 10-point trend, -92.9% 0.17% 0.37% 10.0% 5.7% 2.6% 2.3% 2.8% 1.6% 1.8% 2.4% · ·
Earnings Yield 12-point trend, -618.6% -15.9% 1.1% 13.5% 11.0% 6.6% 4.4% 5.9% 3.7% 3.3% 3.6% 5.5% 3.1%
Payout Ratio 10-point trend, -101.6% -1.0% 34.2% 73.5% 49.9% 38.9% 51.7% 45.4% 41.5% 55.5% 66.7% · ·
Annual Payout 10-point trend, -98.4% $195.0K $715.0K $73M $72M $64M $53M $35M $23M $15M $12M · ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $386M$602M$1.07B$1.60B$1.53B
Bruttogewinnmarge % 71.3%73.8%72.4%71.3%73.9%
Betriebsgewinnmarge % -3.7%0.48%11.8%11.6%14.2%
Nettoergebnis $-19M$2M$99M$144M$164M
Verwässerte EPS $-1.70$0.19$9.10$12.73$13.89
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Liquiditätsgrad 4.73.32.41.61.8
Quick Ratio 3.92.51.00.60.6
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $1M$17M$141M$178M$60M

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 125 Einreicher · $86.3M gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
31 (+4 vs. Vorquartal) 24 (+7 vs. Vorquartal) 47 (+10 vs. Vorquartal) 26 (0 vs. Vorquartal) +421K

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
RENAISSANCE TECHNOLOGIES LLC $8.261.052 778.610 9,57% Aktien
Steamboat Capital Partners, LLC $7.498.076 706.699 8,69% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $5.758.047 542.700 6,67% Kaufoption
TWO SIGMA INVESTMENTS, LP $5.107.452 481.381 5,92% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $4.738.575 446.614 5,49% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $4.212.128 396.996 4,88% Aktien
DIMENSIONAL FUND ADVISORS LP $3.748.163 353.267 4,34% Aktien
AMERICAN CENTURY COMPANIES INC $3.383.646 318.911 3,92% Aktien
CITADEL ADVISORS LLC $2.476.374 233.400 2,87% Kaufoption
AQR CAPITAL MANAGEMENT LLC $2.434.846 229.486 2,82% Aktien
Peapod Lane Capital LLC $2.361.531 222.576 2,74% Aktien
Lido Advisors, LLC $2.337.779 220.337 2,71% Aktien
Trexquant Investment LP $2.256.577 212.684 2,61% Aktien
GOLDMAN SACHS GROUP INC $1.915.975 180.582 2,22% Aktien
COMMONS CAPITAL, LLC $1.590.609 149.916 1,84% Aktien
Quinn Opportunity Partners LLC $1.348.658 127.112 1,56% Aktien
BRIDGEWAY CAPITAL MANAGEMENT, LLC $1.242.198 117.078 1,44% Aktien
RBF Capital, LLC $1.156.490 109.000 1,34% Aktien
Walleye Trading LLC $1.145.880 108.000 1,33% Kaufoption
TWO SIGMA ADVISERS, LP $1.098.972 102.900 1,27% Aktien
MORGAN STANLEY $1.082.586 102.034 1,25% Aktien
JANE STREET GROUP, LLC $1.050.040 98.967 1,22% Aktien
GEODE CAPITAL MANAGEMENT, LLC $1.037.962 97.758 1,20% Aktien
JPMORGAN CHASE & CO $988.562 92.389 1,15% Aktien
Quantinno Capital Management LP $880.598 82.997 1,02% Aktien
Divisadero Street Capital Management, LP $847.092 79.839 0,98% Aktien
Virtus Family Office LLC $838.827 79.060 0,97% Aktien
TUDOR INVESTMENT CORP ET AL $806.689 76.031 0,93% Aktien
BNP PARIBAS FINANCIAL MARKETS $783.846 73.878 0,91% Aktien
VANGUARD GROUP INC $716.276 67.067 0,83% Aktien
BANK OF AMERICA CORP /DE/ $711.295 67.040 0,82% Aktien
CITADEL ADVISORS LLC $696.016 65.600 0,81% Verkaufsoption
VANGUARD FIDUCIARY TRUST CO $672.006 63.337 0,78% Aktien
Atom Investors LP $659.083 62.119 0,76% Aktien
CITADEL ADVISORS LLC $565.555 53.304 0,66% Aktien
STATE STREET CORP $555.105 52.319 0,64% Aktien
Engineers Gate Manager LP $528.686 49.829 0,61% Aktien
MILLENNIUM MANAGEMENT LLC $508.283 47.906 0,59% Aktien
SummerHaven Investment Management, LLC $507.529 47.835 0,59% Aktien
Centiva Capital, LP $471.424 44.432 0,55% Aktien
Susquehanna Portfolio Strategies, LLC $443.254 41.777 0,51% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $422.278 39.800 0,49% Verkaufsoption
VICTORY CAPITAL MANAGEMENT INC $378.300 35.655 0,44% Aktien
Jain Global LLC $373.716 35.223 0,43% Aktien
D. E. Shaw & Co., Inc. $359.424 33.876 0,42% Aktien
PDT Partners, LLC $347.541 32.756 0,40% Aktien
PEAK6 LLC $333.154 31.400 0,39% Kaufoption
XTX Topco Ltd $325.239 30.654 0,38% Aktien
FEDERATED HERMES, INC. $321.578 30.309 0,37% Aktien
Marquette Asset Management, LLC $318.704 30.038 0,37% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $308.836 29.108 0,36% Aktien
NORTHERN TRUST CORP $265.749 25.047 0,31% Aktien
Chico Wealth RIA $222.810 21.000 0,26% Aktien
Point72 Asset Management, L.P. $222.799 20.999 0,26% Aktien
Squarepoint Ops LLC $213.685 20.140 0,25% Aktien
State of Wyoming $197.282 18.594 0,23% Aktien
Walleye Capital LLC $182.492 17.200 0,21% Kaufoption
Empowered Funds, LLC $182.418 17.193 0,21% Aktien
MERCER GLOBAL ADVISORS INC /ADV $178.057 16.782 0,21% Aktien
Brevan Howard Capital Management LP $159.415 15.025 0,18% Aktien
LITTLEJOHN FINANCIAL SERVICES, INC. $146.779 13.834 0,17% Aktien
Advisors Asset Management, Inc. $146.334 8.305 0,17% Aktien
Schonfeld Strategic Advisors LLC $131.212 12.367 0,15% Aktien
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $114.522 10.683 0,13% Aktien
IEQ CAPITAL, LLC $113.951 10.740 0,13% Aktien
Verdad Advisers, LP $108.583 10.234 0,13% Aktien
CWM, LLC $92.056 9.034 0,11% Aktien
BlackRock, Inc. $84.678 7.981 0,10% Aktien
Arax Advisory Partners $79.257 7.470 0,09% Aktien
RHUMBLINE ADVISERS $68.804 6.485 0,08% Aktien
Tower Research Capital LLC (TRC) $63.618 5.996 0,07% Aktien
MARSHALL WACE, LLP $58.025 5.469 0,07% Aktien
Russell Investments Group, Ltd. $49.782 4.692 0,06% Aktien
Vanguard Global Advisers, LLC $41.612 3.922 0,05% Aktien
Walleye Trading LLC $36.074 3.400 0,04% Aktien
AlphaQuest LLC $22.086 2.068 0,03% Aktien
FMR LLC $21.995 2.073 0,03% Aktien
WELLS FARGO & COMPANY/MN $20.859 1.966 0,02% Aktien
Walleye Capital LLC $16.976 1.600 0,02% Verkaufsoption
Walleye Capital LLC $15.406 1.452 0,02% Aktien
PNC Financial Services Group, Inc. $13.432 1.266 0,02% Aktien
Integrated Wealth Concepts LLC $11.289 1.064 0,01% Aktien
GAMMA Investing LLC $11.056 1.042 0,01% Aktien
CREATIVE FINANCIAL DESIGNS INC /ADV $10.610 1.000 0,01% Aktien
BARCLAYS PLC $8.753 825 0,01% Aktien
Jump Financial, LLC $8.488 800 0,01% Aktien
SIGNATUREFD, LLC $7.395 697 0,01% Aktien
Pinnacle Wealth Planning Services, Inc. $6.695 631 0,01% Aktien
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $6.124 601 0,01% Aktien
JONES FINANCIAL COMPANIES LLLP $6.055 576 0,01% Aktien
Allworth Financial LP $5.550 523 0,01% Aktien
C M BIDWELL & ASSOCIATES LTD $5.273 497 0,01% Aktien
Nuveen Asset Management, LLC $5.092 289 0,01% Aktien
IFP Advisors, Inc $4.658 439 0,01% Aktien
UBS Group AG $3.639 343 0,00% Aktien
GREAT LAKES ADVISORS, LLC $3.427 323 0,00% Aktien
Versant Capital Management, Inc $3.289 310 0,00% Aktien
GILL CAPITAL PARTNERS, LLC $1.101 108 0,00% Aktien
MJT & Associates Financial Advisory Group, Inc. $1.061 100 0,00% Aktien
True Wealth Design, LLC $955 90 0,00% Aktien

Unternehmensinsider 49 Insider · 21 Führungskräfte · 26 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Daniel R Chard Chairman & CEO 5. Mai 2022 P 108.598 0 0 $0
Michael S Mcdevitt Chief Executive Officer 5. Januar 2011 S 340.012 0 0 $0
James P. Maloney Chief Financial Officer 20. Juli 2022 F 2.944 0 0 $0
Timothy G Robinson Chief Financial Officer 20. Februar 2020 F 47.214 0 0 $0
Connors Brendan Chief Financial Officer 5. Januar 2011 S 91.484 0 0 $0
Mehrnaz Mona Ameli President, OPTAVIA 17. November 2017 F 10.809 0 0 $0
Margaret Macdonald Sheetz President & COO 1. April 2016 S 327.346 0 0 $0
Jonathan Barrett Mackenzie VP, Finance & CAO 16. März 2022 A 657 0 0 $0
Stephen Kyle Johnson VP, Finance & CAO 17. März 2021 A 665 0 0 $0
Joseph P Kelleman Vice President of Finance 20. Februar 2019 A 2.355 0 0 $0
Jason L Groves Executive VP & General Counsel 17. Februar 2015 A 21.697 0 0 $0
Jeanette M. Mills Executive Vice President 18. August 2014 S 20.116 0 0 $0
Guy Sheetz Executive Vice President 5. Februar 2014 A 410.430 0 0 $0
Dominick Vietri Executive Vice President 5. Februar 2014 A 3.804 0 0 $0
Brian Lloyd Executive Vice President 5. Februar 2014 A 1.865 0 0 $0
Donald Gould Executive Vice President 5. Februar 2014 A 6.804 0 0 $0
Brian Kagen Executive Vice President 5. Februar 2014 A 3.804 0 0 $0
Jeanne M Uphouse Executive Vice President 5. Februar 2014 A 3.804 0 0 $0
Brazdley T Macdonald Exec. Chairman of the Board 5. Januar 2011 S 579.521 0 0 $0
Leo Williams Executive Vice President 29. November 2010 S 15.000 0 0 $0
Robert J Hallock Corporate Vice President 18. November 2003 P 1.000 0 0 $0
Jeffrey J Brown Direktor 9. August 2022 P 3.940 0 0 $0
Andrea B Thomas Direktor 8. August 2022 A 3.014 0 0 $0
Ming Xian Direktor 8. August 2022 A 0 0 $0
Michael A. Hoer Direktor 8. August 2022 A 5.138 0 0 $0
Scott Schlackman Direktor 8. August 2022 A 7.260 0 0 $0
Constance J. Hallquist Direktor 8. August 2022 A 7.882 0 0 $0
Kevin G Byrnes Direktor 11. November 2021 M 14.922 0 0 $0
Michael C Macdonald Direktor 1. Oktober 2020 S 266.179 0 0 $0
Carl E Sassano Direktor 17. Juli 2020 G 18.199 0 0 $0
Charles P Connolly Direktor 9. März 2018 M 41.374 0 0 $0
Welling Glenn W. Direktor 1. Dezember 2017 S 22.380 0 0 $0
Jorgene K. Hartwig Direktor 13. März 2017 M 9.808 0 0 $0
Barry B Bondroff Direktor 11. Juni 2015 S 14.533 0 0 $0
John P Mcdaniel Direktor 4. Juni 2015 S 18.289 0 0 $0
Jerry D Reece Direktor 17. Februar 2015 A 8.792 0 0 $0
Harvey C Barnum JR Direktor 17. Februar 2015 A 8.742 0 0 $0
Catherine T Maguire Direktor 17. Februar 2015 A 15.074 0 0 $0
Donald F Reilly Direktor 17. Februar 2015 A 0 0 0 $0
George Lavin Direktor 31. Juli 2013 D 24.785 0 0 $0
Joseph D Calderone Direktor 24. März 2009 A 21.700 0 0 $0
Carthy Dennis Mc Direktor 24. März 2009 A 17.075 0 0 $0
Michael J Mcdevitt Direktor 15. Februar 2007 A 17.400 0 0 $0
VISIUM BALANCED MASTER FUND, LTD. 10%-Eigentümer 31. Mai 2016 S 0 0 0 $0
Shirley Macdonald 12. Mai 2010 S 0 0 0 $0
Mary T Travis 17. Dezember 2009 S 12.583 0 0 $0
Richard J Law 13. August 2009 S 62.081 0 0 $0
RNI-NV Limited Partnership 8. August 2005 S 1.088.830 0 0 $0
Scott Zion 28. Juli 2004 P 185.000 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 7 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Steamboat Capital Partners, LLC, Parsa Kiai 20. März 2026 6,00% Erste Einreichung SEC
Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest X, LP, Engaged Capital Co-Invest X-A, LP, Engaged Capital Opportunities Fund, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×5 Einreichungen 15. Juli 2020 Erste Einreichung SEC
Engaged Capital Master Feeder II, LP, Engaged Capital Master Feeder I, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling 3. Juni 2016 Erste Einreichung SEC
ModusLink Securities Corp., ModusLink Global Solutions, Inc. ×6 Einreichungen 19. Januar 2016 Erste Einreichung SEC
Engaged Capital Master Feeder I, LP, Engaged Capital Master Feeder II, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×4 Einreichungen 1. September 2015 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 12. Dezember 2002 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 6. Mai 2002 Erste Einreichung Passive Anlage SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 34 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
VRIG · Invesco Actively Managed Exchange-T… 0,27% 5.000.000 8. August 2026 Täglich
FSCC · Federated Hermes ETF Trust 0,13% 28.502 NS 31. Mai 2026 N-PORT
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0,09% 48.444 NS 30. April 2026 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0,05% 377.616 NS 31. Mai 2026 N-PORT
SMLF · iShares Trust 0,03% 121.862 SH 8. August 2026 Täglich
IWC · iShares Trust 0,03% 36.501 SH 8. August 2026 Täglich
SFGV · EA Series Trust 0,02% 17.218 NS 29. Mai 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0,01% 9.249 NS 31. Mai 2026 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0,01% 232.366 NS 31. Mai 2026 N-PORT
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 16.856 SH 8. August 2026 Täglich
DFSV · Dimensional ETF Trust 0,01% 61.752 NS 30. April 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0,01% 16.693 NS 31. Mai 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 13.206 SH 8. August 2026 Täglich
FNDB · SCHWAB STRATEGIC TRUST 0,00% 4.892 NS 31. Mai 2026 N-PORT
RSSL · Global X Funds 0,00% 4.682 NS 30. April 2026 N-PORT
ITWO · ProShares Trust 0,00% 508 NS 31. Mai 2026 N-PORT
DFAS · Dimensional ETF Trust 0,00% 37.570 NS 30. April 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,00% 50.935 NS 31. Mai 2026 N-PORT
UWM · ProShares Trust 0,00% 397 NS 31. Mai 2026 N-PORT
URTY · ProShares Trust 0,00% 404 NS 31. Mai 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 2.019 NS 30. April 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 384 NS 31. Mai 2026 N-PORT
HDG · ProShares Trust 0,00% 10 NS 31. Mai 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 4.578 NS 31. Mai 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 7.873 NS 31. Mai 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 2.079 NS 30. April 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 5.600 NS 30. April 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 115.543 SH 8. August 2026 Täglich
VTI · VANGUARD INDEX FUNDS 0,00% 318.980 SH 8. August 2026 Täglich
VXUS · VANGUARD STAR FUNDS 0,00% 64.351 SH 8. August 2026 Täglich
VGK · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 9.806 SH 8. August 2026 Täglich
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 3.076 SH 8. August 2026 Täglich
VEA · VANGUARD TAX-MANAGED FUNDS 0,00% 42.929 SH 8. August 2026 Täglich
VSGX · VANGUARD WORLD FUND 0,00% 1.003 SH 8. August 2026 Täglich